Significance of measuring serum concentrations of remnant lipoproteins and apolipoprotein B-48 in fasting period

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 1, 2009, Pages 12-20

  Sato, Itsuko ^a   Ishikawa, Yuichi ^b   Ishimoto, Ai ^b   Katsura, Shiho ^b   Toyokawa, Atsushi ^b   Hayashi, Fujio ^a   Kawano, Seiji ^a   Fujioka, Yoshio ^c   Yamashita, Shizuya ^d   Kumagai, Shunichi ^a,e  

^a KOBE UNIVERSITY HOSPITAL   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c KOBE GAKUIN UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dense LDL C; Postprandial hyperlipidemia; RemL C; RLP C; Small

Indexed keywords

APOLIPOPROTEIN B48; CHOLESTEROL; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HYPERLIPIDEMIA; IMMUNOADSORPTION; LIPOPROTEIN BLOOD LEVEL; MALE; TEST MEAL;

EID: 67549099964     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E596     Document Type: Article

References (32)

1. Zilversmit DB: Atherogenesis: a postprandial phenomenon. Circulation, 1979; 60:473-485
2. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, Chin-On S, Hofman A, Cresswell SR, Havekes L: Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb, 1991; 11:653-662
3. Patsch JR, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, Gotto AM. Jr, Patsch W: Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb, 1992; 12:1336-1345
4. Karpe F, Hamsten A: Postprandial lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol, 1995; 6:123-129
5. Davignon J, Cohn JS: Triglycerides: a risk factor for coronary heart disease. Atherosclerosis, 1996; 124(Suppl):S57-S64
6. Yu KC, Cooper AD: Postprandial lipoproteins and atherosclerosis. Front Biosci, 2001; 6:D332-D354
7. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H: Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation; 1999; 99:2858-2860
8. Nakamura T, Takano H, Umetani K, Kawabata K, Obata JE, Kitta Y, Kodama Y, Mende A, Ichigi Y, Fujioka D, Saito Y, Kugiyama K: Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. Atherosclerosis, 2005; 181:321-327
9. Twickler TB, Dallinga-Thie GM, Cohn JS, Chapman MJ: Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype. Circulation, 2004; 109:1918-1925
10. Redgrave TG: Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J Clin Invest, 1970; 49:465-471
11. Imaizumi K, Fainaru M, Havel RJ: Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins. J Lipid Res, 1978; 19:712-722
12. Cooper AD: Hepatic uptake of chylomicron remnants. J Lipid Res, 1997; 38:2173-2192
13. Mahley RW, Ji ZS: Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res, 1999; 40:1-16
14. Sakai N, Uchida Y, Ohashi K, Hibuse T, Saika Y, Tomari Y, Kihara S, Hiraoka H, Nakamura T, Ito S, Yamashita S, Matsuzawa Y: Measurement of fasting serum apo B-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. J Lipid Res, 2003; 44:1256-1262
15. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Shirahashi N, Kita T: Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb, 2006; 13:202-208
16. Hirano T, Ito Y, Yoshino G: Measurement of small dense low-density lipoprotein particles. J Atheroscler Thromb, 2005; 12:67-72
17. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Campos E, Havel RJ: Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta, 1993; 223:53-71
18. Miyauchi K, Kayahara N, Ishigami M, Kuwata H, Mori H, Sugiuchi H, Irie T, Tanaka A, Yamashita S, Yamamura T: Development of a homogeneous assay to measure remnant lipoprotein cholesterol. Clin Chem, 2007; 53:2128-2135
19. Sato I, Taniguchi T, Ishikawa Y, Kusuki M, Hayashi F, Mukai M, Kawano S, Kondo S, Yamashita S, Kumagai S: The lipoprotein fraction between VLDL and LDL detected by biphasic agarose gel electrophoresis reflects serum remnant lipoprotein and Lp(a) concentrations. J Atheroscler Thromb, 2006; 13:55-61
20. Kido T, Kurata H, Matsumoto A, Tobiyama R, Musha T, Hayashi K, Tamai S, Utsunomiya K, Tajima N, Fidge N, Itakura H, Kondo K: Lipoprotein analysis using agarose gel electrophoresis and differential staining of lipids. J Atheroscler Thromb, 2001; 8:7-13
21. Sato I, Hyakuta M, Hayashi F, Mukai M, Kondo S, Maeda E, Kumagai S: Usefulness of examination of the cholesterol versus triglyceride ratio for lipoprotein fractions in a patient with marked hyper-triglyceridemia. Rinsho Byori, 2002; 50:987-991
22. Karpe F: Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med, 1999; 246:341-355
23. Heath RB, Karpe F, Milne RW, Burdge GC, Wootton SA, Frayn KN: Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period. J Lipid Res, 2003; 44:2065-2272
24. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science, 1988; 240:622-630
25. Fujioka Y, Cooper AD, Fong LG: Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages. J Lipid Res, 1998; 39:2339-2349
26. Yamashita S, Sakai N, Hirano K, Ishigami M, Maruyama T, Nakajima N, Matsuzawa Y: Roles of plasma lipid transfer proteins in reverse cholesterol transport. Front Biosci, 2001; 6:D366-D387
27. Taskinen MR, Smith U: Lipid disorders in NIDDM: implications for treatment. J Intern Med, 1998; 244:361-370
28. Nakada Y, Kurosawa H, Tohyama J, Inoue Y, Ikewaki K: Increased remnant lipoprotein in patients with coronary artery disease - evaluation utilizing a newly developed remnant assay, remnant lipoproteins cholesterol homogenous assay (RemL-C). J Atheroscler Thromb, 2007; 14:56-64
29. Shachter NS: Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol, 2001; 12:297-304
30. Westerterp M, de Haan W, Berbée JF, Havekes LM, Rensen PC: Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL. J Lipid Res, 2006; 47:1203-1211
31. Fojo SS, Brewer HB: Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J Intern Med, 1992; 231:669-677
32. Ogita K, Ai M, Tanaka A, Ito Y, Hirano T, Yoshino G, Shimokado K: Serum concentration of small dense low-density lipoprotein-cholesterol during oral glucose tolerance test and oral fat tolerance test. Clin Chem Acta, 2008; 387:36-41